NCT00884546 - Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Advanced Cancer, Various, NOS

Interventions

DRUG

BMS-833923

Capsule, Oral, Once daily, 6 months

DRUG

Lenalidomide

Capsule, Oral, Once daily, 6 months

DRUG

Dexamethasone

Capsule, Oral, Once a week, 6 months

DRUG

Bortezomib

Powder, IV, On days 1, 4, 8, 11, 6 months

Trial Locations (8)

The Sidney Kimmel Comprehensive Cancer Center, Baltimore

Local Institution, Detroit

Oncology Consultants, Pa, Houston

Cancer Therapy And Research Center, San Antonio

Local Institution, Los Angeles

City Of Hope National Medical Center, Duarte

Moores Ucsd Cancer Center, La Jolla

John Theurer Cancer Center, Hackensack